Fin Cascade
Get Android appGet iOS app

Prices as of 8 Oct 2026 close · Not investment advice

Indraprastha Medical Corporation Limited

NSE: INDRAMEDCOHospital

Share price

₹319.90

-2.88% close of 8 Oct 2026

Market cap ₹2,943 CrP/E 15.7

Business score

How strong the business is, in one number. The parts behind it are in Pro.

70

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹2,943 Cr

P/E ratio

15.7

P/B ratio

4.0

ROCE

35.8%

ROE

27.5%

Dividend yield

1.2%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹622.8052-week low ₹319.90

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 10.9% over the past year, and 8.3% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 12.7% to 17.9% over the last four years.

Whether it grew faster than its sector

It grew 8.3% a year against a sector median of 13.1% — 4.7 percentage points slower.

Room to re-rate, or risk of de-rating

At 15.7× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 56.8×, across 5 companies. It is against its own five-year median of 17.5×, the 40th percentile of its own range.

Whether growth justifies the valuation

Priced at 0.6 times its growth rate, on earnings growth of 28%.

Profit growthPrice per ₹1 profitPer 1% growth
Indraprastha Medical Corporation Limited — this one28%/yr15.7×₹0.56
Apollo Hospitals32%/yr52.5×₹1.6
MANIPALHOS22%/yr101.7×₹4.6
Max Healthcare Institute10%/yr56.8×₹5.7
Aster DM Healthcare Limited-1%/yr163.5×—
Fortis Healthcare Limited27%/yr54.0×₹2.0

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Hospital), it ranks 1 of 24 on returns, 20 of 23 on growth, 20 of 25 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

A wide advantage: it earns 35.8% on capital, ahead of 96% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹762 crore of cash from the business, spent ₹238 crore on plant and equipment, and returned ₹153 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 146 arrived as cash (before interest, which is why it can exceed the profit).

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

9 of 9 checks clear · 100%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Revenue up 11% from a year ago and profit up 10% to INR56 crore

Announced 6 Aug 2026 · Standalone · Unaudited

Revenue

₹406 Cr

Revenue vs last year

+11.3%

Revenue vs last quarter

+11.3%

Net profit

₹56 Cr

Profit vs last year

+9.5%

Profit vs last quarter

+33.0%

Net margin

13.8%

EPS

₹6.09

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹2,943 Cr
Prev close
₹319.90
52w High
₹641
52w Low
₹317
Enterprise value
₹2,717 Cr
Beta
1.4
Price CAGR 1y
-40.0%
Price CAGR 3y
23.0%
Price CAGR 5y
33.0%
Price CAGR 10y
20.0%

Ratios

Return on assets
18.6%
PEG ratio
0.6
P/E ratio
15.7
P/B ratio
4.0
EV / EBITDA
9.9
Industry P/E
52.4
ROCE
35.8%
ROCE 5y average
35.2%
ROE
27.5%
Debt / Equity
0.0
Interest coverage
42.0
Dividend yield
1.2%
ROE 3y average
29.0%
ROE last year
27.0%

Annual P&L

Annual revenue
₹1,483 Cr
Annual profit
₹184 Cr
Operating margin
18.0%
Net profit margin
12.4%
EBITDA margin
18.0%
Sales growth 3y
10.5%
Sales growth 5y
19.3%
Profit growth 3y
28.0%
Profit growth 5y
132.0%
EPS
₹20.0
Sales growth TTM
11.0%
Profit growth TTM
12.0%
Dividend payout
20.0%

Quarter P&L

Sales latest quarter
₹406 Cr
Profit latest quarter
₹56 Cr
YoY quarterly sales growth
11.3%
YoY quarterly profit growth
9.8%
OPM latest quarter
19.6%

Balance Sheet

Book Value
₹80.5
Face Value
₹10.0
Total debt
₹37 Cr
Total cash
₹263 Cr
Borrowings
₹37 Cr
Reserves / Equity
7.1

Cash Flow

Operating cash flow
₹167 Cr
Free cash flow
₹108 Cr
FCF yield
3.5%
Net cash flow
-₹57 Cr

Shareholding

Promoter holding
51.0%
FII holding
2.8%
DII holding
0.6%
Public holding
45.6%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Apollo Hospitals7,917.0054.11,13,8340.25610.434.27,043.520.617.4
Manipal Health699.15103.991,9650.00243.4-7.93,090.638.112.1
Max Healthcare908.0059.088,3770.22323.04.92,366.216.714.7
Aster DM Quality680.30164.359,3000.4429.3-46.11,310.721.611.6
Fortis Health.779.1055.158,8190.13272.83.42,545.017.513.4
Narayana Hrudaya1,723.2040.935,2150.26207.35.72,683.678.015.5
Global Health1,294.1060.834,7950.04157.3-0.21,304.126.517.4
Indrapr.Medical329.4016.13,0201.2155.98.5406.211.335.8
Median406.3249.35,7570.0230.219.9399.422.314.7

Competes with: Apollo Hospitals, Aster DM Healthcare Limited, Fortis Healthcare Limited, Global Health Limited, Krishna Institute of Medical Sciences Limited, MANIPALHOS, Max Healthcare Institute, Narayana Hrudayalaya Ltd.

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Standalone · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales307317306315348350325334365381372365406
Expenses259267259266281286273272292310310304326
Material Cost596365646470
Change in Inventories000000
Purchases of Stock-in-Trade000000
Employee Cost676574757473
Other Expenses147164171171166183
Operating Profit47504748676452617371626180
OPM %15161515191816182019171720
Other Income4445565677778
Exceptional items (within Other Income)000000
Interest1112222122112
Depreciation10101010111111111011111112
Profit before tax40444142605745556866565575
Tax %24252825252626262525272425
Net Profit30332931454233415149414256
EPS in Rs3.333.583.213.404.884.633.584.475.615.404.474.556.09
Diluted EPS in Rs4.475.615.404.474.550

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Standalone · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7147557667537888316138881,0991,2451,3561,4831,524
Expenses6306756866787067435727689471,0501,1121,2151,250
Material Cost230256
Change in Inventories00
Purchases of Stock-in-Trade00
Employee Cost277288
Other Expenses605672
Operating Profit85807974828741120152195245267274
OPM %1211101010117141416181818
Other Income11-0-1-1-0-0-3916222830
Exceptional items (within Other Income)00
Interest87897633446.276.026
Depreciation28353131303333353940444445
Profit before tax503941344548479117166216246253
Tax %34373638369462626252625
Net Profit32242621284425986124161184188
EPS in Rs3.542.662.862.303.104.760.256.399.4014182021
Diluted EPS in Rs1820
Dividend Payout %5168636552003932332620

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
7%
5 years
19%
3 years
11%
TTM
11%

Compounded profit growth

10 years
22%
5 years
132%
3 years
28%
TTM
12%

Stock price CAGR

10 years
20%
5 years
33%
3 years
23%
1 year
-40%

Return on equity

10 years
21%
5 years
27%
3 years
29%
Last year
27%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital929292929292929292929292
Reserves103132139141152176181234288386505649
Borrowings50526766214352343337
Other Liabilities196185160134157177157131173212222214
Total Liabilities442460458432422449432462555723852991
Fixed Assets286301296294280303283277275347328365
CWIP3300103030333
Investments000000000000
Other Assets153157163138141146145185278376491624
Total Assets442460458432422449432462555723852991

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6462284875862794144200157167
Cash from Investing Activity-29-33-22-30-17-40-19-74-108-158-111-178
Cash from Financing Activity-35-30-5-17-44-43-3-3-26-32-46-46
Net Cash Flow-0-0-01144517119-0-57
Free Cash Flow35295175846665100131121107

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days404147413535401823172028
Inventory Days11
Days Payable182
Cash Conversion Cycle404147413535401823172028
Working Capital Days-35-22-17-7-5-10-1-2-12-24-19-4
ROCE %23181715192132934383936

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Standalone · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters515151515151515151515151
FIIs0.810.951.081.702.642.882.942.732.412.722.432.77
DIIs6.716.364.913.143.193.183.563.563.510.820.870.59
Public414243444343434343454646
No. of Shareholders47,86551,44854,15855,10364,67169,69770,49170,21170,91471,22572,98075,098

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -42.4% (₹555.30 → ₹319.90)Brick size ₹10.95 (fixed)Bricks 68
₹400₹500₹600₹320Nov '25Jan '26Mar '26May '26Jul '26Oct '26
Price moved up one brickPrice moved down one brickLast close ₹319.90 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

-226inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

49,43,333inr

2026-03-31

News

News and filings about Indraprastha Medical Corporation Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • Medicines and medical consumables
  • Stores, spares and medical equipment (partly imported, USD-denominated)
  • Surgical / pharmacy consumables

Buys from

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Healthcare
Industry
Hospital
Classification
Healthcare › Hospital
ISIN
INE681B01017

Plants

  • Apollo Hospitals Noida · Noida, Uttar Pradesh
  • Indraprastha Apollo Hospitals complex

News impact

Big market events that reach Indraprastha Medical Corporation Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

18 Sep 2026unspecified₹4
18 Sep 2025unspecified₹4.5
13 Sep 2024unspecified₹4.5
15 Sep 2023unspecified₹3
15 Sep 2022unspecified₹2.5
12 Sep 2019unspecified₹1.6
12 Sep 2018unspecified₹1.5
14 Sep 2017unspecified₹1.8

Splits, bonuses & buybacks

  • daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.